9 stories found
Nvidia reported exceptional second-quarter financial results, with quarterly revenue doubling to nearly $100 billion as demand for artificial intelligence chips continues to accelerate. Alongside the earnings beat, the company announced expanded capital investments and resumed high-end chip sales to the Chinese market.
HealthEquity shares saw gains after BMO Capital Markets upgraded the company's stock, citing a positive long-term growth outlook.
HealthEquity announced a Non-GAAP EPS of $0.95, surpassing estimates by $0.05, and revenue of $334.6 million, which also beat expectations by $1.78 million.
Financial analysts have provided their perspectives and insights on the performance and outlook of healthcare companies Becton Dickinson (BDX), Agios Pharma (AGIO), and Healthequity (HQY).
HealthEquity, Inc. has released its fourth-quarter 2026 earnings call summary, detailing the company's financial performance for the period.
Hedge fund Boone Capital has acquired a stake in HealthEquity, prompting an analysis into whether the company's stock presents a favorable buying opportunity for investors.
HealthEquity has outlined a fiscal 2027 revenue projection of $1.41B-$1.42B and announced an expansion of its share repurchase authorization by $1 billion.
HealthEquity (HQY) has released its earnings transcript for the fourth quarter of fiscal year 2026, detailing its financial performance.
Jefferies has highlighted HealthEquity, Inc. (HQY) as a defensive investment option, given its exposure to both healthcare and technology sectors.